Named Patient Medicines

Trulicity Dulaglutide Injection is an agonist of the GLP-1 receptor. In some cases, the drug can cause acute renal failure, or worsen chronic renal failure, and may require hemodialysis. While some adverse reactions were reported in patients with no known renal disease, the majority of patients with adverse reactions also had impaired renal function. Therefore, TRULICITY should be used with caution in patients with renal impairment, and renal function should be monitored periodically. Trulicity DULAGLUTIDE Injection Heart rate A limited number of studies have examined the safety and efficacy of Trulicity Dulaglutide Injection in pregnant women. However, these studies have not been conducted in sufficient numbers to draw definitive conclusions. While the drug is generally safe, the possibility of serious adverse effects, including birth defects, should be considered. This medication should be used with caution, especially in women with poorly controlled diabetes. Gastric emptying Despit

  There are few known side effects of LENVIMA 10MG Capsules, but the drug is associated with some adverse reactions. The most common adverse reactions were diarrhea, hypertension, decreased appetite, and decreased weight. In addition, some patients had serious adverse reactions, including dehydration, hypotension, and palmar-plant erythrodysesthesia syndrome. In addition, the drug is associated with a high incidence of hepatic dysfunction and renal failure. LENVIMA 10MG Capsules is not recommended for children younger than two years of age. There is no data to support its safety in children. It is important to follow the directions provided by your healthcare provider to avoid side effects. Furthermore, it is important to note that the drug should only be used for the intended indication. LENVIMA 10MG Capsules is a prescription medicine for the treatment of certain cancers. It is used alone in patients with differentiated thyroid cancer, which has not responded to radioactive iodine.